7Baggers

We provide you with 20 years of free, institutional-grade data for NARI stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of NARI. Explore the full financial landscape of NARI stock.

Reported DateCIKTickerType
2024-10-281531048NARI10-QUrl
2024-07-301531048NARI10-QUrl
2024-04-301531048NARI10-QUrl
2024-02-291531048NARI10-KUrl
2023-11-011531048NARI10-QUrl
2023-08-021531048NARI10-QUrl
2023-05-031531048NARI10-QUrl
2023-02-271531048NARI10-KUrl
2022-11-021531048NARI10-QUrl
2022-08-031531048NARI10-QUrl
2022-05-041531048NARI10-QUrl
2022-02-231531048NARI10-KUrl
2021-11-091531048NARI10-QUrl
2021-08-101531048NARI10-QUrl
2021-05-111531048NARI10-QUrl
2021-03-091531048NARI10-KUrl
2020-11-121531048NARI10-QUrl
2020-08-111531048NARI10-QUrl
2020-02-211531048NARIS-1Url

Inari Medical, Inc
(NASDAQ:NARI) 

NARI stock logo

Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States. It offers ClotTriever for treatment of deep vein thrombosis; and FlowTriever, a thrombectomy system for tre...

Founded: 2011
Full Time Employees: 199
CEO: William H. Hoffman  
Sector: Healthcare
Industry: Medical Devices

Share this website to your friends
The information provided in this report about NARI stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.